A multicenter, randomized controlled study on the efficacy of agomelatine in ameliorating anhedonia, reduced motivation, and circadian rhythm disruptions in patients with major depressive disorder (MDD).
Ann Gen Psychiatry
; 22(1): 46, 2023 Nov 13.
Article
in En
| MEDLINE
| ID: mdl-37957751
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Ann Gen Psychiatry
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: